Testing effectiveness (Phase 2)Not Yet RecruitingNCT07489300
What this trial is testing
Benmelstobart in Combination With Anlotinib and Oral Metronomic Cyclophosphamide in the Treatment of Recurrent Epithelial OvariaN, Fallopian Tube, or Primary Peritoneal Cancer
Who this might be right for
Ovarian CancerFallopian Tube CancersPrimary Peritoneal Cancer
Second Affiliated Hospital, Zhejiang University, School of Medicine 40